Evidence map›Paper›PMID 36674623›Full record

ArticleInternational journal of molecular sciences2023

Effectiveness of Flattening-Filter-Free versus Flattened Beams in V79 and Glioblastoma Patient-Derived Stem-like Cells.

Valentina Dini, Giuseppe Esposito, Andrea Sacconi, Marco D'Andrea, Maria Antonella Tabocchini, Pasquale Anello, Lucia Ricci-Vitiani, Mariachiara Buccarelli, Roberto Pallini, Lidia Strigari

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Valentina DiniNational Center for Innovative Technologies in Public Health, Istituto Superiore di Sanità, 00161 Rome, Italy.ORCID 0000-0003-4125-0084
Giuseppe EspositoNational Center for Innovative Technologies in Public Health, Istituto Superiore di Sanità, 00161 Rome, Italy.
Andrea SacconiUOSD Clinical Trial Center, Biostatistics and Bioinformatics, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.
Marco D'AndreaLaboratory of Medical Physics, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.ORCID 0000-0003-0517-6163
Maria Antonella TabocchiniIstituto Nazionale di Fisica Nucleare (INFN), Sezione di Roma 1, 00185 Rome, Italy.ORCID 0000-0003-3244-6106
Pasquale AnelloNational Center for Innovative Technologies in Public Health, Istituto Superiore di Sanità, 00161 Rome, Italy.
Lucia Ricci-VitianiDepartment of Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy.ORCID 0000-0001-7336-5615
Mariachiara BuccarelliDepartment of Oncology and Molecular Medicine, Istituto Superiore di Sanità, 00161 Rome, Italy.ORCID 0000-0003-1157-4694
Roberto PalliniInstitute of Neurosurgery, Università Cattolica del Sacro Cuore, IRCCS Fondazione Policlinico A. Gemelli, 00168 Rome, Italy.ORCID 0000-0002-4611-8827
Lidia StrigariDepartment of Medical Physics, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.ORCID 0000-0003-4293-2298
Istituto Nazionale di Fisica Nucleare · ITIstituto Superiore di Sanità · ITAzienda USL di Bologna · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITUniversità Cattolica del Sacro Cuore · IT

Funding

National Institute for Nuclear Physics CSN5 RADIOSTEM experiment
6 · The paper itself

Abstract

Literature data on the administration of conventional high-dose beams with (FF) or without flattening filters (FFF) show conflicting results on biological effects at the cellular level. To contribute to this field, we irradiated V79 Chinese hamster lung fibroblasts and two patient-derived glioblastoma stem-like cell lines (GSCs-named #1 and #83) using a clinical 10 MV accelerator with FF (at 4 Gy/min) and FFF (at two dose rates 4 and 24 Gy/min). Cell killing and DNA damage induction, determined using the γ-H2AX assay, and gene expression were studied. No significant differences in the early survival of V79 cells were observed as a function of dose rates and FF or FFF beams, while a trend of reduction in late survival was observed at the highest dose rate with the FFF beam. GSCs showed similar survival levels as a function of dose rates, both delivered in the FFF regimen. The amount of DNA damage measured for both dose rates after 2 h was much higher in line #1 than in line #83, with statistically significant differences between the two dose rates only in line #83. The gene expression analysis of the two GSC lines indicates gene signatures mimicking the prognosis of glioblastoma (GBM) patients derived from a public database. Overall, the results support the current use of FFF and highlight the possibility of identifying patients with candidate gene signatures that could benefit from irradiation with FFF beams at a high dose rate.

Indexed as

GlioblastomaHumansLungRadiotherapy DosageRadiotherapy Planning, Computer-AssistedDNA damagedose ratesflattening filtersglioblastoma-like cell linesV79 cells

Identifiers

PMID36674623
PMCPMC9861147
OpenAlexW4313646841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.